We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
-11.95%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
AUM
$270M
AUM Growth
-$91.5M
Cap. Flow
-$47.5M
Cap. Flow %
-17.6%
Top 10 Hldgs %
29.27%
Holding
186
New
6
Increased
34
Reduced
74
Closed
23

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$7.06M
2
UNH icon
UnitedHealth
UNH
+$6.09M
3
ZTS icon
Zoetis
ZTS
+$5.52M
4
ULTA icon
Ulta Beauty
ULTA
+$3.73M
5
VZ icon
Verizon
VZ
+$479K

Top Sells

Rank Stock Value
1
APH icon
Amphenol
APH
+$7.85M
2
PSX icon
Phillips 66
PSX
+$7.78M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$7.68M
4
SCHW
Charles Schwab
SCHW
+$7.42M
5
CTAS icon
Cintas
CTAS
+$7.25M

Sector Composition

Rank Sector Weight
1 Healthcare 24.65%
2 Technology 17.48%
3 Financials 9.53%
4 Industrials 8.75%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
126
Kimberly-Clark
KMB
$36.5B
$272K 0.1%
2,390
+200
+9% +$22.2K
UBSI icon
127
United Bankshares
UBSI
$6.62B
$270K 0.1%
8,685
GE icon
128
GE Aerospace
GE
$384B
$259K 0.1%
7,139
-143
-2% -$6.46K
VO icon
129
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$259K 0.1%
7,500
-852
-10% -$32K
NDSN icon
130
Nordson
NDSN
$17.3B
$254K 0.09%
2,125
EFV icon
131
iShares MSCI EAFE Value ETF
EFV
$29.4B
$253K 0.09%
5,599
-43
-0.8% -$2.07K
NEE icon
132
NextEra Energy
NEE
$177B
$247K 0.09%
5,688
HALO icon
133
Halozyme
HALO
$12.2B
$244K 0.09%
16,702
LUMN icon
134
Lumen
LUMN
$6.44B
$244K 0.09%
16,127
-1,525
-9% -$29.1K
MRSH
135
Marsh
MRSH
$91.5B
$241K 0.09%
3,026
VMC icon
136
Vulcan Materials
VMC
$36.9B
$237K 0.09%
2,400
V icon
137
Visa
V
$677B
$234K 0.09%
1,775
BMO icon
138
Bank of Montreal
BMO
$127B
$228K 0.08%
3,488
MPC icon
139
Marathon Petroleum
MPC
$83.7B
$224K 0.08%
3,798
+40
+1% +$2.73K
OTEX icon
140
Open Text
OTEX
$6.04B
$224K 0.08%
6,870
BDX icon
141
Becton Dickinson
BDX
$48.2B
$218K 0.08%
990
MLNX
142
DELISTED
Mellanox Technologies, Ltd.
MLNX
$217K 0.08%
+2,350
New +$200K
ZBH icon
143
Zimmer Biomet
ZBH
$18.4B
$212K 0.08%
2,109
AMGN icon
144
Amgen
AMGN
$222B
$211K 0.08%
1,085
FAST icon
145
Fastenal
FAST
$59.5B
$210K 0.08%
16,080
SAP icon
146
SAP
SAP
$238B
$207K 0.08%
2,075
NVDA icon
147
NVIDIA
NVDA
$5.42T
$206K 0.08%
61,800
+8,000
+15% +$38.3K
MNP
148
DELISTED
Western Asset Municipal Partners Fund, Inc.
MNP
$204K 0.08%
14,650
EMR icon
149
Emerson Electric
EMR
$88.3B
$203K 0.08%
3,405
-104,833
-97% -$7.07M
JKHY icon
150
Jack Henry & Associates
JKHY
$11.1B
$203K 0.08%
1,605

Similar funds

Dixon Hubard Feinour & Brown's Q4 2018 Portfolio in Review

As of Q4 2018, Dixon Hubard Feinour & Brown held 186 positions worth $270M, down 25% from $362M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Dixon Hubard Feinour & Brown withdrew a net $47.5M in Q4 2018, closing 23 positions and reducing 74 holdings. Its most notable exit was Amphenol, an estimated $7.85M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 17% a quarter earlier, followed by Technology and Financials.

Against the trend, Dixon Hubard Feinour & Brown opened a new position in Edwards Lifesciences worth $7.12M.

  • Dixon Hubard Feinour & Brown's largest Q4 2018 buy was Edwards Lifesciences: 139,536 shares worth $7.12M.
  • Dixon Hubard Feinour & Brown added most to UnitedHealth in Q4 2018, an estimated $6.09M increase.
  • Dixon Hubard Feinour & Brown's biggest Q4 2018 reduction was iShares Russell 2000 ETF, cutting an estimated $7.68M.
  • Dixon Hubard Feinour & Brown fully exited Amphenol in Q4 2018, selling an estimated $7.85M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 29% of its $270M portfolio in Q4 2018.
  • Dixon Hubard Feinour & Brown opened 6 new positions and closed 23 in Q4 2018.
  • Dixon Hubard Feinour & Brown's portfolio value fell 25% quarter-over-quarter to $270M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2018, filed 13 Feb 2019.